|

Rituximab and Hyaluronidase Human Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Also known as: Rituxan Hycela, Rituximab Plus Hyaluronidase, Rituximab/Hyaluronidase, Rituximab/Hyaluronidase Human

Pipeline

Phase 3: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Follicular Lymphoma With Unusual Cytological Features1
  • Classic Follicular Lymphoma1
  • Cancer1

Birmingham, Alabama1 trial

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

University of Alabama at Birmingham Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.